| Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma (NCT00023998) | National Cancer Institute (NCI) | 2001-07-01 |
| SU6668 in Treating Patients With Advanced Solid Tumors (NCT00024206) | National Cancer Institute (NCI) | 2001-07-01 |
| Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00023959) | National Cancer Institute (NCI) | 2001-07-01 |
| BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors (NCT00022529) | National Cancer Institute (NCI) | 2001-07-01 |
| Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma (NCT00430079) | National Cancer Institute (NCI) | 2001-07-01 |
| PS-341 in Treating Patients With Metastatic Malignant Melanoma (NCT00024011) | National Cancer Institute (NCI) | 2001-07-01 |
| Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young Adulthood (NCT00026806) | National Cancer Institute (NCI) | 2001-07-01 |
| Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT00024089) | National Cancer Institute (NCI) | 2001-07-01 |
| Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00015912) | National Cancer Institute (NCI) | 2001-07-01 |
| Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia (NCT00023920) | National Cancer Institute (NCI) | 2001-07-01 |
| Genetic Epidemiology of Lung Cancer and Smoking (NCT00340340) | National Cancer Institute (NCI) | 2001-06-28 |
| Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer (NCT00016107) | National Cancer Institute (NCI) | 2001-06-01 |
| Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer (NCT00021099) | National Cancer Institute (NCI) | 2001-06-01 |
| Bortezomib in Treating Patients With Lymphoproliferative Disorders (NCT00023764) | National Cancer Institute (NCI) | 2001-06-01 |
| Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00020709) | National Cancer Institute (NCI) | 2001-06-01 |
| Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia (NCT00025038) | National Cancer Institute (NCI) | 2001-06-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment (NCT00022438) | National Cancer Institute (NCI) | 2001-06-01 |
| BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00022542) | National Cancer Institute (NCI) | 2001-06-01 |
| Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 (NCT00006435) | National Cancer Institute (NCI) | 2001-05-18 |
| Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer (NCT00016549) | National Cancer Institute (NCI) | 2001-05-13 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00021164) | National Cancer Institute (NCI) | 2001-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00021073) | National Cancer Institute (NCI) | 2001-05-01 |
| CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00016328) | National Cancer Institute (NCI) | 2001-05-01 |
| STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia (NCT00015834) | National Cancer Institute (NCI) | 2001-05-01 |
| Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma (NCT00021229) | National Cancer Institute (NCI) | 2001-05-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer (NCT00016276) | National Cancer Institute (NCI) | 2001-05-01 |
| Bortezomib in Treating Patients With Recurrent Glioma (NCT00006773) | National Cancer Institute (NCI) | 2001-05-01 |
| EMD 121974 in Treating Patients With Advanced Solid Tumors (NCT00022113) | National Cancer Institute (NCI) | 2001-05-01 |
| The Second Multicenter Hemophilia Cohort Study (NCT00341705) | National Cancer Institute (NCI) | 2001-04-27 |
| Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions (NCT00026793) | National Cancer Institute (NCI) | 2001-04-23 |
| Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients (NCT00026767) | National Cancer Institute (NCI) | 2001-04-09 |
| Thalidomide in Treating Patients With Myelodysplastic Syndrome (NCT00015990) | National Cancer Institute (NCI) | 2001-04-01 |
| Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00012298) | National Cancer Institute (NCI) | 2001-04-01 |
| Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) (NCT00341146) | National Cancer Institute (NCI) | 2001-04-01 |
| Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia (NCT00017472) | National Cancer Institute (NCI) | 2001-04-01 |
| Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas (NCT00012181) | National Cancer Institute (NCI) | 2001-04-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan (NCT00016978) | National Cancer Institute (NCI) | 2001-04-01 |
| Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma (NCT00017381) | National Cancer Institute (NCI) | 2001-04-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00016302) | National Cancer Institute (NCI) | 2001-04-01 |
| Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer (NCT00017251) | National Cancer Institute (NCI) | 2001-04-01 |
| S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00016094) | National Cancer Institute (NCI) | 2001-04-01 |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies (NCT00013533) | National Cancer Institute (NCI) | 2001-03-14 |
| Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma (NCT00007345) | National Cancer Institute (NCI) | 2001-03-08 |
| Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma (NCT00005949) | National Cancer Institute (NCI) | 2001-03-01 |
| Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00014170) | National Cancer Institute (NCI) | 2001-03-01 |
| Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma (NCT00017316) | National Cancer Institute (NCI) | 2001-03-01 |
| Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer (NCT00017394) | National Cancer Institute (NCI) | 2001-03-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer (NCT00020540) | National Cancer Institute (NCI) | 2001-03-01 |
| Research in Skin Inflammation (NCT00026741) | National Cancer Institute (NCI) | 2001-03-01 |
| 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors (NCT00012194) | National Cancer Institute (NCI) | 2001-03-01 |
| Caspofungin Acetate in Treating Children With Fever and Neutropenia (NCT00020527) | National Cancer Institute (NCI) | 2001-03-01 |
| Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer (NCT00012376) | National Cancer Institute (NCI) | 2001-03-01 |
| PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck (NCT00011778) | National Cancer Institute (NCI) | 2001-02-22 |
| Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors (NCT00011414) | National Cancer Institute (NCI) | 2001-02-15 |
| Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma (NCT00006184) | National Cancer Institute (NCI) | 2001-02-08 |
| Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer (NCT00020410) | National Cancer Institute (NCI) | 2001-02-01 |
| Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States (NCT00026728) | National Cancer Institute (NCI) | 2001-02-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye (NCT00020475) | National Cancer Institute (NCI) | 2001-02-01 |
| Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia (NCT00016016) | National Cancer Institute (NCI) | 2001-02-01 |
| Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors (NCT00020488) | National Cancer Institute (NCI) | 2001-02-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma (NCT00020462) | National Cancer Institute (NCI) | 2001-02-01 |
| EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection (NCT00006436) | National Cancer Institute (NCI) | 2001-01-29 |
| Natural History of Patients With Brain and Spinal Cord Tumors (NCT00009035) | National Cancer Institute (NCI) | 2001-01-22 |
| Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma (NCT00005576) | National Cancer Institute (NCI) | 2001-01-01 |
| Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00020449) | National Cancer Institute (NCI) | 2001-01-01 |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia (NCT00005786) | National Cancer Institute (NCI) | 2001-01-01 |
| Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00004888) | National Cancer Institute (NCI) | 2001-01-01 |
| Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors (NCT00007917) | National Cancer Institute (NCI) | 2001-01-01 |
| Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study (NCT00006425) | National Cancer Institute (NCI) | 2000-12-19 |
| Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer (NCT00006518) | National Cancer Institute (NCI) | 2000-12-06 |
| Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer (NCT00010192) | National Cancer Institute (NCI) | 2000-12-01 |
| Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia (NCT00005808) | National Cancer Institute (NCI) | 2000-12-01 |
| Benzoylphenylurea in Treating Patients With Advanced Cancer (NCT00010205) | National Cancer Institute (NCI) | 2000-12-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00005856) | National Cancer Institute (NCI) | 2000-12-01 |
| Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer (NCT00022373) | National Cancer Institute (NCI) | 2000-12-01 |
| Arsenic Trioxide in Treating Patients With Urothelial Cancer (NCT00009867) | National Cancer Institute (NCI) | 2000-12-01 |
| SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment (NCT00009919) | National Cancer Institute (NCI) | 2000-12-01 |
| Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor (NCT00009906) | National Cancer Institute (NCI) | 2000-12-01 |
| Late Effects of Treatment for Sarcomas in Children (NCT00006515) | National Cancer Institute (NCI) | 2000-11-16 |
| Capravirine to Treat Children With HIV Infection (NCT00006519) | National Cancer Institute (NCI) | 2000-11-01 |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00009971) | National Cancer Institute (NCI) | 2000-11-01 |
| BMS-247550 in Treating Patients With Advanced Cancers (NCT00006221) | National Cancer Institute (NCI) | 2000-11-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer (NCT00009958) | National Cancer Institute (NCI) | 2000-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma (NCT00007956) | National Cancer Institute (NCI) | 2000-11-01 |
| Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma (NCT00020397) | National Cancer Institute (NCI) | 2000-11-01 |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia (NCT00006363) | National Cancer Institute (NCI) | 2000-11-01 |
| Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors (NCT00006450) | National Cancer Institute (NCI) | 2000-11-01 |
| Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study (NCT00006421) | National Cancer Institute (NCI) | 2000-10-25 |
| Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00006942) | National Cancer Institute (NCI) | 2000-10-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma (NCT00006243) | National Cancer Institute (NCI) | 2000-10-01 |
| SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas (NCT00005862) | National Cancer Institute (NCI) | 2000-10-01 |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer (NCT00006389) | National Cancer Institute (NCI) | 2000-10-01 |
| Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer (NCT00006486) | National Cancer Institute (NCI) | 2000-10-01 |
| Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00020332) | National Cancer Institute (NCI) | 2000-10-01 |
| Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00006089) | National Cancer Institute (NCI) | 2000-09-18 |
| Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance) (NCT00341757) | National Cancer Institute (NCI) | 2000-09-12 |
| Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols (NCT00026689) | National Cancer Institute (NCI) | 2000-09-11 |
| BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy (NCT00020371) | National Cancer Institute (NCI) | 2000-09-01 |
| Vaccine Therapy in Treating Patients With Melanoma (NCT00020358) | National Cancer Institute (NCI) | 2000-09-01 |